Skip to content

CorMedix CRMD Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin92.9%0.0pp92.9%94.3%+72.3pp
Operating margin48.2%-46,819.9%-31,402pp
Net margin52.3%-45,409.9%-30,635pp
EBITDA margin52.8%-46,690.5%-31,306pp
Free cash flow margin55.4%+172pp-116.7%-37,573.5%-25,747pp
Returns
Return on equity66.6%-74%-23.6pp-50.4%+2.3pp
Return on assets34.5%-64.3%-19.0pp-45.4%+2.4pp
Return on invested capital97.4%-248%+22.3pp-270.3%+171pp
Efficiency
Asset turnover0.7×+0.2×0.4×0.0×
Inventory turnover1.2×+0.6×0.6×
Liquidity
Current ratio2.1×-1.3×3.4×-3.6×-2.5×9.4×-3.0×
Quick ratio1.9×-1.2×3.2×-3.6×6.8×-2.7×9.4×-3.0×
Cash ratio0.8×-0.4×1.2×-2.6×3.8×-3.0×6.9×-3.1×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×
Net debt / EBITDA-0.9×
Interest coverage54×-1,427.5×-272×-1,155×+691×
Per Share
Book value per share$5.05+251%$1.44+4.4%$1.38+0.8%$1.37-18.0%
Valuation
Market capitalization$605.65M-34.4%$491.49M+138%$206.09M+18.3%$174.21M+0.5%
Enterprise value$774.78M+71.7%$451.25M+177%$162.94M+23.8%$131.64M+9.1%
Price / earnings3.4×
Price / sales1.5×-9.6×11.3×2,663.4×+1,756×
Price / book1.4×-6.6×5.8×+2.9×2.9×-0.2×3.2×+0.4×
EV / EBITDA4.7×
EV / sales2.5×-7.9×10.4×2,012.6×+1,381×
Free cash flow yield32.1%+33.6pp-10.3%+8.5pp-18.8%-4.7pp-14.1%-1.1pp
Earnings yield29.9%-22.5%-5.4pp-17%-0.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are CorMedix's profit margins?
CorMedix (CRMD) runs a 91.9% gross margin and a 48.4% operating margin, with a 45.2% net margin.
Where do CorMedix's ratios come from?
Every ratio is computed from CorMedix's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.